More on AMLX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-2.7% Growth)
- Ratings (8.3 Score)
- Holders

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Amylyx Pharmaceuticals (NQ:AMLX)
Delayed: 26.34 -1.31 (4.74%)
Prev. Close $27.65  
Open$27.65 
52 Wk High$ 
52 Wk Low$ 
Day High$27.65 
Day Low$26.20 
P/E N/A  
EPS$ 
Volume1,150,594 

Friends, Peers and Foes (?): HUM, FIVE, BAX, HTZ, TMCI (more...)

Oct 7, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Oct 05 Filed by: MILNE GEORGE M JR
Oct 6, 2026 08:01 AM Amylyx to present Phase 3 avexitide trial data at ObesityWeek 2026
Oct 6, 2026 08:00 AM Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
Oct 5, 2026 04:38 PM Form 144 Amylyx Pharmaceuticals, Filed by: MILNE GEORGE M JR
Oct 1, 2026 07:24 AM Amylyx Pharmaceuticals (AMLX) Reiterated at Buy by Stifel on Ph3 Data for Avexitide
Sep 23, 2026 09:00 AM Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Bedrosian Camille L
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: FRATES JAMES M
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Klee Justin B.
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Mazzariello Gina
View All Articles

Entities mentioned with AMLX

View All Entities